AJP - Renal AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (February 13, 2008). doi:10.1152/ajprenal.00596.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/F928    most recent
00596.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basile, D. P.
Right arrow Articles by Parrish, A. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basile, D. P.
Right arrow Articles by Parrish, A. R
Submitted on December 18, 2007
Accepted on February 6, 2008

Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor

David P. Basile1*, Katherine Fredrich2, Bhadrani Chelladurai1, Ellen C Leonard3, and Alan R Parrish4

1 Department of Cellular and Integrative Physiology, Indiana University, Indianaoplis, Indiana, United States
2 Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3 Department of Cellular and Integrative Physiology, ndiana University, Indiana, United States
4 Systems Biology, Texas A&M Health Science Ctr, College Station, Texas, United States

* To whom correspondence should be addressed. E-mail: dpbasile{at}iupui.edu.

Reductions in vascular density occur following acute ischemia reperfusion (I/R) injury that may predispose the development of chronic kidney disease. The mechanisms mediating vascular loss are not clear but may relate to the lack of effective vascular repair responses. To determine the regulation of the VEGF/VEGFR pathway following I/R injury, male SD rats were subjected to bilateral renal ischemia (45 min) and allowed to recover for 1, 3, 7, and 35 days. VEGF mRNA expression was repressed by greater than 50% of control values up to 3 days post-ischemia, while VEGF protein was repressed for up to 7 days post-ischemia. The renal mRNA expression of receptors was not altered post-ischemia, however, VEGFR1 (flt-1) protein was transiently reduced in kidney while soluble flt-1 was elevated in plasma at 7 days following injury. Microarray analysis of angiogenesis related genes identified the enhanced expression of a number of genes, among these was ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin motif-1), a secreted VEGF inhibitor. The altered expression of ADAMTS-1 was confirmed using RT-PCR and Western blot analysis; its expression proximal tubules following I/R injury. Other genes identified using microarray included aminopeptidase N, Smad-1, and Id-3 and their localization was also examined using immunohistochemistry. In summary, the data indicate no clear pattern of anti-angiogenic gene expression following renal I/R injury. However the studies do suggest an overall inhibition of the VEGF pathway during the early injury and repair phase of renal ischemia that may contribute to an overall reduction in renal microvascular density




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. C. Leonard, J. L. Friedrich, and D. P. Basile
VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1648 - F1657.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.